Cao De-quan, Chen Yan-ping, Chang Ye-tian, Li Yong-guo
Department of Anesthesiology, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2006 Feb;31(1):94-6.
To investigate the effects of aminoguanidine on the lung injury induced by the total hepatic ischemia-reperfusion in rats.
The total hepatic ischemia-reperfusion model was built after blocking of the hepatic porta, suprahepatic and infrahepatic vena cava. Ninety Sprague-Dawley rats were assigned randomly into 3 groups: Sham operation group (Group A, n=30); total hepatic ischemia group (Group B, n=30); and aminoguanidine treatment group (Group C, n=30). Each group was subdivided randomly into 3 subgroups (n=10) according to different time phases: 20 minutes after the total hepatic vascular exclusion (T0), 4 hours after the reperfusion (T1), and 48 hours after the survival Group A and Group B were intravenously injected with normal saline ( mL/kg) while Group C was injected with aminoguanidine (20 mg/kg) dissolved in normal saline (1 mL/kg) 10 minutes before the open of the abdomin. The levels of portal blood nitric oxide ( O) endotoxin ( ET), tumor necrosis factor-alpha (TNF-alpha at T0 and T1 were detected; 48 hours survival rates and the lung wet/dry weight ratio were counted; and the histological changes of the lung tissues were observed.
Compared with Group A, the levels of portal vein NO, ET, and TNF-alpha T0 and T1 in Group B and Group C were significantly higher (P < 0.05 or P < 0.01). But those indexes of Group C were lower than those of Group B (P < 0.05). The 48-hour survival rate in Group C was higher than that in Group B (P < 0.05). The lung wet/dry weight ratio in Group C was lower than in Group B (P < 0.05) and the histological change of Group C was slighter than that in Group B.
Aminoguanidine has the protective effects on the lungs against the total hepatic ischemia-reperfusion induced injury.
探讨氨基胍对大鼠全肝缺血再灌注诱导的肺损伤的影响。
在阻断肝门、肝上下腔静脉和肝下下腔静脉后建立全肝缺血再灌注模型。90只Sprague-Dawley大鼠随机分为3组:假手术组(A组,n = 30);全肝缺血组(B组,n = 30);氨基胍治疗组(C组,n = 30)。每组根据不同时间阶段随机再分为3个亚组(n = 10):全肝血管阻断后20分钟(T0)、再灌注后4小时(T1)、存活48小时后。A组和B组静脉注射生理盐水( mL/kg),而C组在开腹前10分钟注射溶解于生理盐水(1 mL/kg)的氨基胍(20 mg/kg)。检测T0和T1时门静脉血一氧化氮(NO)、内毒素(ET)、肿瘤坏死因子-α(TNF-α)水平;计算48小时存活率和肺湿/干重比;观察肺组织的组织学变化。
与A组相比,B组和C组在T0和T1时门静脉NO、ET和TNF-α水平显著升高(P < 0.05或P < 0.01)。但C组的这些指标低于B组(P < 0.05)。C组48小时存活率高于B组(P < 0.05)。C组肺湿/干重比低于B组(P < 0.05),且C组组织学变化比B组轻微。
氨基胍对全肝缺血再灌注诱导的肺损伤具有保护作用。